
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI
[ Wed, Mar 23rd 2022 ]: WOPRAI

[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI
[ Tue, Mar 22nd 2022 ]: WOPRAI

[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
[ Mon, Mar 21st 2022 ]: WOPRAI
Yatin Suneja Downgraded (ANAB) to Hold on, Mar 22nd, 2022


🞛 This publication is a summary or evaluation of another publication
Yatin Suneja of Guggenheim, Downgraded "AnaptysBio, Inc." (ANAB) to Hold on, Mar 22nd, 2022.
Yatin has made no other calls on ANAB in the last 4 months.
There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with Yatin's Rating of Hold.
This is the rating of the analyst that currently disagrees with Yatin
- Michael King of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $46 on, Tuesday, March 8th, 2022